Epigenomics · 2023 · 15 citations · 33 references
MedicineCancer BiologyOncologyGene ExpressionMolecular OncologyTumor ProgressionCancer Cell SignalingCancer GenomicsEpithelial-mesenchymal TransitionEpithelial-to-mesenchymal TransitionSignal Transduction In CancerTumor Suppressor GenesEpithelial-mesenchymal Transition In CancerEpithelial-mesenchymal Transition MarkersImmunoprecipitation AssaysLung AdenocarcinomaPull-down AssaysRna ImmunoprecipitationTumor Growth DynamicsXenograft Survival
Aim: To explore the roles of GMDS-AS1 in the epithelial–mesenchymal transition (EMT) of lung adenocarcinoma (LUAD). Materials & methods: Cell functions were detected by flow cytometry, cell counting kit-8, wound healing assays and transwell assays. RNA immunoprecipitation and pull-down assays were applied for determining the interaction among GMDA-AS1, TAF15 and SIRT1. A subcutaneous xenograft model was established. Results: GMDS-AS1 downregulation was associated with poor survival of LUAD patients. GMDS-AS1 repressed malignant phenotypes, tumor growth and EMT in vitro and in vivo. Mechanically, GMDS-AS1 recruited TAF15 protein to stabilize SIRT1 mRNA and thereby deacetylated p65 and reduced the recruitment of p65 to MMP-9 promoter, thus inhibiting MMP-9 expression. Conclusion: GMDS-AS1 represses EMT by recruiting TAF15 protein to stabilize SIRT1 mRNA and deacetylate p65, thus restraining LUAD progression.
33
A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression
Yul W. Yang, Amartya Sanyal, M. Ryan Corces et al. · Nature · 2011 · 2K citations
Metastatic patterns in adenocarcinoma
Kenneth R. Hess, Gauri R. Varadhachary, Sarah Taylor et al. · Cancer · 2006 · 819 citations · Full text